{{Rsnum
|rsid=6039763
|Gene=SNAP25-AS1
|Chromosome=20
|position=10202869
|Orientation=plus
|GMAF=0.4022
|Gene_s=SNAP25-AS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 35.5 | 42.7 | 21.8
| HCB | 6.7 | 22.2 | 71.1
| JPT | 9.9 | 48.6 | 41.4
| YRI | 7.6 | 38.2 | 54.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 6.7 | 22.2 | 71.1
| CHD | 11.3 | 36.8 | 51.9
| GIH | 18.0 | 48.0 | 34.0
| LWK | 9.1 | 50.0 | 40.9
| MEX | 14.0 | 42.1 | 43.9
| MKK | 5.8 | 45.5 | 48.7
| TSI | 27.5 | 52.0 | 20.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=2E-6
  |OR=5.97
  |ORtxt=[2.502-14.23]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}